PIK3CA and colorectal cancer: Multiple studies have demonstrated that proportions of colorectal cancers with specific molecular features such as MSI, high-level CIMP, and BRAF and PIK3CA mutations gradually increase along the bowel subsites from rectum to ascending colon [7–9].